From the blog

Catalyzing Informed Action: Webinar Series & Patient Survey

The U.S. Food and Drug Administration (FDA) will host a workshop on drug development and CFS and ME on April 25-26, 2013. This FDA workshop will... Read More

Putting the Patient at the Center: FDA’s New Series Premiers with ME/CFS

It’s rare that ME/CFS as a disease category experiences a “first” that’s positive. Here’s one worth celebrating: the March 11, 2013... Read More

CFS Advisory Committee Meets May 22-23

The federal Chronic Fatigue Syndrome Advisory Committee (CFSAC) meets next on May 22-23, 2013 in Washington, D.C. This chartered advisory committee... Read More

CFIDS Association Announces Leadership Transition

The CFIDS Association of America announces that longtime president and CEO, K. Kimberly McCleary, will be leaving her role as the organization’s... Read More

You’re At the Center: Learn How the CFIDS Association is Fostering Developing of Safe and Effective Treatments for ME/CFS

The fourth webinar in our spring series focuses on how the CFIDS Association is fostering the development of safe and effective therapies for ME/CFS.... Read More

Find Out How FDA Defines “Safe and Effective”: April 11 Webinar

View the third webinar in spring series: http://bit.ly/apr-11-webinar, recorded on April 11. In just about two weeks, the U.S. Food and Drug Administration... Read More

Upcoming Webinar: Finding Your Strongest Voice for Public Testimony

The upcoming FDA Workshop on Drug Development is a historic opportunity for the ME/CFS* community to establish ME/CFS as a priority for drug development.... Read More